Financhill
Back

Alnylam Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:
$326.86
Seasonality Move:
-0.46%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

Alnylam Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 329.2 Sell
20-day SMA: 329.48 Sell
50-day SMA: 359.37 Sell
200-day SMA: 390.18 Sell
8-day EMA: 327.31 Sell
20-day EMA: 333.46 Sell
50-day EMA: 357.5 Sell
200-day EMA: 371.7 Sell

Alnylam Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.2 Sell
Relative Strength Index (14 RSI): 37.32 Sell
Chaikin Money Flow: -209216 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (320.99 - 344.45) Sell
Bollinger Bands (100): (351.71 - 457.75) Sell

Alnylam Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Alnylam Pharmaceuticals, Inc. Stock

Is Alnylam Pharmaceuticals, Inc. Stock a Buy?

ALNY Technical Analysis vs Fundamental Analysis

Sell
30
Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. a Buy or a Sell?

Alnylam Pharmaceuticals, Inc. Stock Info

Market Cap:
42.3B
Price in USD:
318.65
Share Volume:
947.6K

Alnylam Pharmaceuticals, Inc. 52-Week Range

52-Week High:
495.55
52-Week Low:
205.87
Sell
30
Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Alnylam Pharmaceuticals, Inc. Share Price Forecast

Is Alnylam Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Alnylam Pharmaceuticals, Inc.

Is Alnylam Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.94 per share, an increase next quarter of $0.76 per share, an increase this year of $4.77 per share, and an increase next year of $4.98 per share.

Technical Analysis of Alnylam Pharmaceuticals, Inc.

Should I short Alnylam Pharmaceuticals, Inc. stock?

* Alnylam Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.